IBSA FARMACEUTICI ITALIA SRL
🇮🇹Italy
- Country
- 🇮🇹Italy
- Ownership
- Subsidiary
- Established
- 1992-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.ibsa.it
Safety and Efficacy Evaluation of Sodium Hyaluronate 32mg/ml in Improving Facial Skin Dryness and Dullness
Not Applicable
Recruiting
- Conditions
- Facial DrynessFacial Dullness
- First Posted Date
- 2025-04-06
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- IBSA Farmaceutici Italia Srl
- Target Recruit Count
- 500
- Registration Number
- NCT06914583
- Locations
- 🇨🇳
West China Hospital of Stomatology Sichuan Hospital, Chengdu, China
🇨🇳Peking Union Medical College Hospital (PUMCH), Beijing, China
🇨🇳Peking University First Hospital, Beijing, China
Evaluation of the Effects of Two Dietary Supplement Formulations on the Lipid Profile in Mild Hypercholesterolemia
Not Applicable
Recruiting
- Conditions
- Hypercholesterolemia and HyperlipidemiaSupplementation
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- IBSA Farmaceutici Italia Srl
- Target Recruit Count
- 99
- Registration Number
- NCT06810466
- Locations
- 🇮🇹
S. Orsola-Malpighi University Hospital, Bologna, Italy
Evaluation of the Safety and Efficacy of Profhilo® Structura
Recruiting
- Conditions
- Skin Aging
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- IBSA Farmaceutici Italia Srl
- Target Recruit Count
- 164
- Registration Number
- NCT06719154
- Locations
- 🇫🇷
Eurofins Dermscan Pharmascan, Villeurbanne, Lyon, France
🇵🇱Eurofins Dermscan Poland, Gdansk, Poland
🇵🇱Aesthetic clinical, Poznan, Poland
Assessment of the Adjuvant Role of Dietary Supplementation of Antibiotic-tolerant Probiotics in Standard Therapy for the Eradication of Helicobacter Pylori Infection.
Not Applicable
Recruiting
- Conditions
- Helicobacter Pylori Infection
- Interventions
- Dietary Supplement: IBSA ProbioticsDietary Supplement: Placebo
- First Posted Date
- 2024-07-12
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- IBSA Farmaceutici Italia Srl
- Target Recruit Count
- 270
- Registration Number
- NCT06499649
- Locations
- 🇮🇹
Policlinico S. Orsola - Malpighi - Università di Bologna, Bologna, Italy
Effect of Phaseolus Vulgaris L. Dry Extract on the Modulation of Weight and Metabolic Parameters
Not Applicable
Recruiting
- Conditions
- Weight Loss
- Interventions
- Dietary Supplement: Phaseolus Vulgaris L. Dry ExtractDietary Supplement: Placebo
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- IBSA Farmaceutici Italia Srl
- Target Recruit Count
- 60
- Registration Number
- NCT06193577
- Locations
- 🇮🇹
A.O.U. Policlinico "G. Rodolico - San Marco", Catania, Italy
Efficacy Evaluation of an ODF Iron Supplement Vs an Iron Supplement in Capsules in Subjects with Mild Anemia
Not Applicable
Completed
- Conditions
- Iron Deficiencies
- Interventions
- Dietary Supplement: Iron Supplement in CapsulesDietary Supplement: ODF Iron Supplement
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- IBSA Farmaceutici Italia Srl
- Target Recruit Count
- 23
- Registration Number
- NCT05989984
- Locations
- 🇮🇹
Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Roma, Italy
Evaluation of Safety and Tolerability of Salvia Haenkei Extract As a Dietary Supplement Ingredient
Not Applicable
Recruiting
- Conditions
- Aging
- Interventions
- Dietary Supplement: Salvia haenkei 350mgDietary Supplement: Salvia haenkei 175mg
- First Posted Date
- 2023-07-07
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- IBSA Farmaceutici Italia Srl
- Target Recruit Count
- 50
- Registration Number
- NCT05936346
- Locations
- 🇨ðŸ‡
Ospedale Regionale di Lugano, Lugano, Switzerland
Safety and Efficacy of Intralesional HiLow Hyaluronic Acid in the Treatment of Peyronie's Disease (PD)
Not Applicable
Completed
- Conditions
- Peyronie Disease
- Interventions
- Device: Pre-filled syringe of HiLow Hyaluronic Acid Sodium Salt
- First Posted Date
- 2023-05-23
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- IBSA Farmaceutici Italia Srl
- Target Recruit Count
- 40
- Registration Number
- NCT05871177
- Locations
- 🇮🇹
U.O.C. Urologia, Azienda Ospedaliero Universitaria Mater Domini di Catanzaro, Catanzaro, Italy
🇮🇹Azienda Ospedaliero Universitaria delle Marche, Macerata, Italy
🇮🇹Fondazione IRCSS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy
Evaluation of Efficacy and Safety of HCC_45 for the Correction of Acne Scars of the Face
Not Applicable
Completed
- Conditions
- Rolling ScarsAcne Scars - Mixed Atrophic and HypertrophicBoxcar ScarsIce Pick Scars
- Interventions
- Device: HCC_45
- First Posted Date
- 2023-01-19
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- IBSA Farmaceutici Italia Srl
- Target Recruit Count
- 30
- Registration Number
- NCT05691049
- Locations
- 🇮🇹
DERMING S.r.l., Clinical Research and Bioengineering Institute, Milano, Lombardia, Italy
Cross-over Study to Evaluate the Rate and the Extent of Iron Absorption of an ODF Iron Supplement vs an Iron Supplement in Capsules
Not Applicable
Completed
- Conditions
- Iron-deficiency
- Interventions
- Dietary Supplement: SiderAL® FORTEDietary Supplement: IBSA Iron ODF
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2023-01-11
- Lead Sponsor
- IBSA Farmaceutici Italia Srl
- Target Recruit Count
- 9
- Registration Number
- NCT05660200
- Locations
- 🇮🇹
Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Roma, Italy
© Copyright 2025. All Rights Reserved by MedPath